StockData
Boston Scientific Corp logo

Boston Scientific Corp (BSX) income statement

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3048% below fair value
$43.64+0.61 (+1.42%)

Close on Nov 18, 2026Market cap $63.24BP/E 17.7Yield –

Boston Scientific Corp income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
69.9%
Operating margin
19.8%
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
1.24
Debt to equity
0.51
Debt to assets
27.9%
Cash to current liabilities
8.4%

Valuation

P/E ratio
17.7
Price to sales
3.01
Price to book
2.54
Dividend yield
–

See a number that looks wrong?